Abu Dhabi : Ultrasound continues to be a critical tool, often in conjunction with mammography, for the screening, detection, and characterization of breast cancer. However, ultrasound can have high false-positive rates, which then lead to unnecessary biopsies, increased costs, and discomfort to patients.

In a new study, a team of researchers from NYU Langone and NYU Abu Dhabi (NYUAD) report that they have developed a novel artificial intelligence (AI) system that achieves radiologist-level accuracy in identifying breast cancer in ultrasound images. The system, designed to be a decision support tool for clinicians, also helped radiologists significantly decrease their false positive and requested biopsy rates while maintaining the same level of sensitivity.

NYUAD Assistant Professor Emerging Scholar of Computer Engineering Farah Shamout and colleagues at NYU Langone and NYU Center for Data Science, including PhD student Yiqiu Shen and NYU Assistant Professor Krzysztof Geras, detail their findings in Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams, a paper published in the journal Nature Communications.

The researchers utilized a dataset of more than 280,000 ultrasound exams from over 140,000 patients examined at NYU Langone Health between 2012 and 2019 to develop and test their new system. The system is designed to identify malignant lesions in breast ultrasound images, with the primary goal of reducing the frequency of false positive findings. It can detect cancer by assigning a probability for malignancy and highlighting parts of ultrasound images that are associated with its predictions.

To understand the potential value of this novel AI system in a clinical setting, the researchers conducted a reader study to compare its diagnostic accuracy with ten board-certified breast radiologists. It achieved higher accuracy than the ten radiologists on average, but a hybrid model that aggregated the predictions of the AI system and radiologists achieved the best results in accurately detecting cancer in patients. The performance of the AI system remained robust across patients from different age groups and mammographic breast densities.

“Our findings highlight the potential of AI to improve the accuracy, consistency, and efficiency of breast cancer diagnosis in ultrasound images,” said Shamout. “Importantly, AI is not a replacement for the expertise of clinicians. However, the powerful, complimentary role between AI systems, as decision support tools, and clinicians, leads us to believe that AI should and will be increasingly translated into clinical practice.”

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related deaths among women worldwide.

-Ends-

About NYU Abu Dhabi 

NYU Abu Dhabi is the first comprehensive liberal arts and science campus in the Middle East to be operated abroad by a major American research university. NYU Abu Dhabi has integrated a highly selective liberal arts, engineering and science curriculum with a world center for advanced research and scholarship enabling its students to succeed in an increasingly interdependent world and advance cooperation and progress on humanity’s shared challenges. NYU Abu Dhabi’s high-achieving students have come from more than 115 nations and speak over 115 languages. Together, NYU's campuses in New York, Abu Dhabi, and Shanghai form the backbone of a unique global university, giving faculty and students opportunities to experience varied learning environments and immersion in other cultures at one or more of the numerous study-abroad sites NYU maintains on six continents. 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.